Clinical aspects and pathophysiology of inflammatory bowel disease.
about
Elevated serum procollagen type III peptide in splanchnic and peripheral circulation of patients with inflammatory bowel disease submitted to surgeryEffects of chronic inflammatory bowel diseases on left ventricular structure and function: a study protocol.Stem cell-based therapies in inflammatory bowel disease: promises and pitfallsUlcerative colitis as a polymicrobial infection characterized by sustained broken mucus barrierMovers and shakers: influence of bacteriophages in shaping the mammalian gut microbiotaMolecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseasesRadical induction theory of ulcerative colitisBeauvericin ameliorates experimental colitis by inhibiting activated T cells via downregulation of the PI3K/Akt signaling pathwayTLR5 risk-associated haplotype for canine inflammatory bowel disease confers hyper-responsiveness to flagellinPolymorphisms in the TLR4 and TLR5 gene are significantly associated with inflammatory bowel disease in German shepherd dogsMolecular mimicry may contribute to pathogenesis of ulcerative colitis.Human inflammatory bowel disease does not associate with Lawsonia intracellularis infectionLymphoid tyrosine phosphatase R620W variant and inflammatory bowel disease in Tunisia.Angiopoietin-2 in experimental colitisEmerging prognostic markers to determine Crohn's disease natural history and improve management strategies: a review of recent literature.Preventive effect of a pectic polysaccharide of the common cranberry Vaccinium oxycoccos L. on acetic acid-induced colitis in miceOrally administered glucans from the edible mushroom Pleurotus pulmonarius reduce acute inflammation in dextran sulfate sodium-induced experimental colitis.Tumor necrosis factor-α and Muc2 mucin play major roles in disease onset and progression in dextran sodium sulphate-induced colitisImplications of the colonic deposition of free hemoglobin-α chain: a previously unknown tissue by-product in inflammatory bowel diseaseDoenjang prepared with mixed starter cultures attenuates azoxymethane and dextran sulfate sodium-induced colitis-associated colon carcinogenesis in mice.Effect of probiotics on pro-inflammatory cytokines and NF-kappaB activation in ulcerative colitis.Anti-colitic effects of kanjangs (fermented soy sauce and sesame sauce) in dextran sulfate sodium-induced colitis in mice.Enteral nutrition in Crohn's disease: an underused therapy.Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel diseaseImmunological alteration and changes of gut microbiota after dextran sulfate sodium (DSS) administration in mice.High prevalence of vitamin A deficiency in Crohn's disease patients according to serum retinol levels and the relative dose-response test.Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria.Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease.Protective effect of simvastatin and rosuvastatin on trinitrobenzene sulfonic acid-induced colitis in ratsExpression of NOD2 in Paneth cells: a possible link to Crohn's ileitisResistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibilityBone marrow-derived mesenchymal stem cell transplantation ameliorates oxidative stress and restores intestinal mucosal permeability in chemically induced colitis in mice.A phase II study of laquinimod in Crohn's disease.Development of fatal colitis in FVB mice infected with Citrobacter rodentiumCrohn's Disease: Evolution, Epigenetics, and the Emerging Role of Microbiome-Targeted Therapies.Bactericidal permeability increasing protein gene polymorphism is associated with inflammatory bowel diseases in the Turkish populationRifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections.Regulatory effects of glycyrrhizae radix extract on DSS-induced ulcerative colitisBactericidal/permeability increasing protein gene polymorphism and inflammatory bowel diseases: meta-analysis of five case-control studies.Low bone mass in children and adolescents.
P2860
Q24798856-8A892603-FC73-4508-B635-803D3053124FQ24804514-7D589DEB-EA8D-4122-A2F6-AC8C37FB05ECQ26745715-C75888C2-5803-455D-A773-49477843A9A3Q26825483-68CE13A6-4DB4-49C2-8BB1-F149B306A74EQ26827355-BDAD02F3-7C3F-455B-A5FC-7DB4C1EF00CEQ28131810-88C1FA0F-D2CB-493F-A8E5-2594AF1ADD35Q28245348-719529CA-483D-43DD-BE20-329528F7F233Q28536748-BAF252EE-9188-4034-AE2A-4189494F0F57Q28732734-37067B95-331E-431A-A387-42D18928DB9EQ28743984-CCEACED3-918D-4F27-AF67-470276EA504BQ31162559-D5E8794A-8DAF-4003-9A6D-FDBA8C029E2DQ33258058-E227BC1A-9C89-46C1-99CA-74C595DF3661Q33612241-5BF03714-AB9E-46F2-B718-C47A7FF23A4FQ33897226-5D2B4945-6DFF-45F9-ACEA-E4EC70D5A144Q33916303-202E51C1-E6D4-4A2F-9DC9-F99841A9CC29Q34017747-C5C5B04B-CE4A-4CF5-847A-A6D0D2DF8802Q34019489-C711EAC8-DCD9-4B15-8973-6F0EE073708BQ34031888-4570CA8C-B8DC-4AA1-B2E1-7901A7DC4CE2Q34052630-7FD9FA82-DB9A-4336-B250-DD998825B289Q34077338-06DF5FF1-BFEA-41DD-9C1A-0A7FF18E1E6DQ34101968-0226D7F3-3C5C-4A35-8E5F-0F85B2A43546Q34124662-D94D7C61-89A4-4A3E-852D-B4C3EDB00670Q34395233-3A084F84-916E-478D-B905-07D1B9A79C7AQ34827250-4C3EB1A3-8F00-432F-A1D1-AE2A81C7104DQ35020376-A27E438C-858A-485F-936E-690272430BB9Q35045798-09888010-2199-4994-A876-47A062F37E8AQ35140083-5E26BB75-0EE7-43C4-85C4-8ABD6AEDACC9Q35220907-7193E65B-D2B5-4039-8F79-47B7F9B710BDQ35222372-4BFE6E4C-C42B-46E2-9ED5-111C6768D461Q35596103-B7048666-58EA-4C30-8807-3A421332A701Q35641138-FDE793A4-EADC-452A-90C1-E567D437FB00Q35826470-E94E7307-3BA4-4050-91ED-E6D8B61DEA96Q35891861-A5E18693-770A-4809-BEA5-316DFC7075F8Q35913654-15C5EEF2-149E-41E2-95F7-A77179F09E9DQ35933419-6B444B70-BB28-4FDD-AC2A-1D282B43BA04Q35973799-0038DC07-2DC4-4EC3-8D8A-97DFF3ADC8E5Q36140657-61F93C1B-07AC-4F94-85F2-378A7E831753Q36193382-CE2D08A3-C81A-4074-92F1-CB2982B66CFDQ36236120-92A0AE72-8255-4AFA-A23C-20C1B8388BE6Q36658970-69A27515-7E92-4B6B-99D1-DB862B360F82
P2860
Clinical aspects and pathophysiology of inflammatory bowel disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Clinical aspects and pathophysiology of inflammatory bowel disease.
@ast
Clinical aspects and pathophysiology of inflammatory bowel disease.
@en
Clinical aspects and pathophysiology of inflammatory bowel disease.
@nl
type
label
Clinical aspects and pathophysiology of inflammatory bowel disease.
@ast
Clinical aspects and pathophysiology of inflammatory bowel disease.
@en
Clinical aspects and pathophysiology of inflammatory bowel disease.
@nl
prefLabel
Clinical aspects and pathophysiology of inflammatory bowel disease.
@ast
Clinical aspects and pathophysiology of inflammatory bowel disease.
@en
Clinical aspects and pathophysiology of inflammatory bowel disease.
@nl
P2093
P2860
P1476
Clinical aspects and pathophysiology of inflammatory bowel disease.
@en
P2093
Barbara A Hendrickson
Judy H Cho
Ranjana Gokhale
P2860
P356
10.1128/CMR.15.1.79-94.2002
P407
P577
2002-01-01T00:00:00Z